BioLattice Ophthalmics, Inc, — Form D
BioLattice Ophthalmics, Inc, of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-30. The offering totals $2.5M, of which $575K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-03-30
- Form: D
- Accession: 0002125596-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $575K
- Remaining: $1.9M
- Investors: 2
- Date of first sale: 2026-03-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-578200
Issuer
- Name: BioLattice Ophthalmics, Inc,
- CIK: 0002125596
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 2929 ARCH STREET, PHILADELPHIA, PA, 19104
- Phone: 267-481-5423
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Linda Alunkal | Director | Philadelphia, PA |
| Gregory Jackson | Director | Harrisburg, PA |
| Amelia Zellander | Director | Philadelphia, PA |
| Linda Alunkal | Executive Officer | Philadelphia, PA |
| Amelia Zellander | Executive Officer | Philadelphia, PA |
More